Both studies had a major limitation: at baseline, patients with autoimmune diseases (including rheumatoid arthritis) have more periodontal inflammation than patients without autoimmune diseases and that administering anti- TNF-α therapy as a treatment for rheumatoid arthritis reduces inflammation in periodontal tissues [99,100]. Here, TNF is linked to rheumatoid arthritis.